Nevertheless, lethal bone toxicity and cachexia were observed in FAP+ stromal-cells-depleted murine models, and in clinical trials, anti-FAP inhibitors showed no therapeutic benefit in patients with metastatic colorectal cancer [17,18]. Here, FAP is linked to metastatic colorectal cancer.